Clinical Behavior in Metastatic Brain Disease Is Not Influenced by the Immunological Defense Mediated by CD57+ NK-Cells
Figure 1
Examples of CD57+ NK-cells in the resected brain metastases of the series. NK-cells were generally distributed surrounding the vessels (a) and within the tumor stroma (b). Immunostained CD57+ NK-cells can be seen (×200).
